Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Bicalutamide")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 259

  • Page / 11
Export

Selection :

  • and

Photosensitive drug eruption induced by bicalutamide within the UVB action spectrumSASADA, Kumiko; SAKABE, Jun-Ichi; TAMURA, Aiko et al.EJD. European journal of dermatology. 2012, Vol 22, Num 3, pp 402-403, issn 1167-1122, 2 p.Article

Eosinophilic lung disease induced by bicalutamide : A case report and review of the medical literatureWONG, P. W; MACRIS, N; DIFABRIZIO, L et al.Chest. 1998, Vol 113, Num 2, pp 548-550, issn 0012-3692Article

Characteristics of bicalutamide solid dispersions and improvement of the dissolutionFUZHENG REN; QIUFANG JING; YANHUI TANG et al.Drug development and industrial pharmacy. 2006, Vol 32, Num 8, pp 967-972, issn 0363-9045, 6 p.Article

Effet du bicalutamide 150 mg, à trois ans de suivi médian, dans le cancer de la prostate non métastatique = Effect of bicalutamide 150 mg in non-metastatic prostate cancer with a median follow-up of three years: analysis as a function of previous treatment and prognostic factorsFOURCADE, Richard-Olivier; RICHAUD, Pierre; BRUNE, Daniel et al.Progrès en urologie (Paris). 2003, Vol 13, Num 3, pp 430-439, issn 1166-7087, 10 p.Article

Formation of bicalutamide nanodispersion for dissolution rate enhancementCHAN LI; CAIXIA LI; YUAN LE et al.International journal of pharmaceutics (Print). 2011, Vol 404, Num 1-2, pp 257-263, issn 0378-5173, 7 p.Article

Nanosized bicalutamide and its molecular structure in solventsYUAN LE; HUA JI; CHEN, Jian-Feng et al.International journal of pharmaceutics (Print). 2009, Vol 370, Num 1-2, pp 175-180, issn 0378-5173, 6 p.Article

Conformational polymorphism in bicalutamideVEGA, Daniel R; POLLA, Griselda; MARTINEZ, Andrea et al.International journal of pharmaceutics. 2007, Vol 328, Num 2, pp 112-118, issn 0378-5173, 7 p.Article

Bicalutamide: Clinical pharmacokinetics and metabolismCOCKSHOTT, Ian D.Clinical pharmacokinetics. 2004, Vol 43, Num 13, pp 855-878, issn 0312-5963, 24 p.Article

Physicochemical Characterization of Hot Melt Extruded Bicalutamide-Polyvinylpyrrolidone Solid DispersionsANDREWS, Gavin P; ABUDIAK, Osama A; JONES, David S et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 3, pp 1322-1335, issn 0022-3549, 14 p.Article

Bicalutamide 50 mg monotherapy in patients with isolated high-grade PIN : findings in repeat biopsies at 6 monthsBONO, Aldo V; MAZZUCCHELLI, Roberta; FERRARI, Ilaria et al.Journal of clinical pathology. 2007, Vol 60, Num 4, pp 443-446, issn 0021-9746, 4 p.Article

Adjuvant hormonal treatment for Prostate cancer: The Bicalutamide Early Prostate cancer ProgramWIRTH, Manfred P; FROEHNER, Michael.Oncology. 2003, Vol 65, pp 1-4, issn 0030-2414, 4 p., SUP1Article

Comparative Pharmacokinetic Evaluation of Two Formulations of Bicalutamide 50-mg Tablets: An Open-Label, Randomized-Sequence, Single-Dose, Two-Period Crossover Study in Healthy Korean Male VolunteersLEE, Seunghwan; CHUNG, Yong-Ju; KIM, Bo-Hyung et al.Clinical therapeutics. 2009, Vol 31, Num 12, pp 3000-3008, issn 0149-2918, 9 p.Article

Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostateTAY, M.-H; KAUFMAN, D. S; OH, W. K et al.Annals of oncology. 2004, Vol 15, Num 6, pp 974-978, issn 0923-7534, 5 p.Article

Polymorph Transitions of Bicalutamide : A Remarkable Example of Mechanical ActivationNEMET, Zoltan; SZTATISZ, Janisz; DEMETER, Adam et al.Journal of pharmaceutical sciences. 2008, Vol 97, Num 8, pp 3222-3232, issn 0022-3549, 11 p.Article

Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 GY) significantly reduces the incidence of bicalutamide-induced gynecomastiaTYRRELL, Christopher J; PAYNE, Heather; MORRIS, Tom et al.International journal of radiation oncology, biology, physics. 2004, Vol 60, Num 2, pp 476-483, issn 0360-3016, 8 p.Article

The role of the androgen receptor in triple-negative breast cancerSHAH, Payal D; GUCALP, Ayca; TRAINA, Tiffany A et al.Women's health (London. Print). 2013, Vol 9, Num 4, pp 351-360, issn 1745-5057, 10 p.Article

Bicalutamide-Associated Fulminant HepatotoxicityO'BRYANT, Cindy L; FLAIG, Thomas W; UTZ, Kenneth J et al.Pharmacotherapy. 2008, Vol 28, Num 8, pp 1071-1075, issn 0277-0008, 5 p.Article

Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile studyNAGESWARA RAO, R; NARASARAJU, A; NARSIMHA, R et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 46, Num 3, pp 505-519, issn 0731-7085, 15 p.Article

An improved and validated LC method for resolution of bicalutamide enantiomers using amylose tris-(3,5-dimethylphenylcarbamate) as a chiral stationary phaseNAGESWARA RAO, R; NARASA RAJU, A; NAGARAJU, D et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 42, Num 3, pp 347-353, issn 0731-7085, 7 p.Article

The Relative Bioavailability Study and Fasting and Fed States Pharmacokinetics of Bicalutamide 50-mg Tablets in Healthy Chinese VolunteersLU, H.-M; YE, M.Arzneimittel-Forschung. 2012, Vol 62, Num 1, pp 18-21, issn 0004-4172, 4 p.Article

Relative Bioavailability and Tolerability of Two Formulations of Bicalutamide 50-mg Tablets: A Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Korean Male SubjectsLEE, Seunghwan; SEO HYUN YOON; CHO, Joo-Youn et al.Clinical therapeutics. 2010, Vol 32, Num 14, pp 2496-2501, issn 0149-2918, 6 p.Article

Phytoestrogens derived from Belamcanda chinensis have an antiproliferative effect on prostate cancer cells in vitroMORRISSEY, Colm; BEKTIC, Jasmin; SPENGLER, Barbara et al.The Journal of urology. 2004, Vol 172, Num 6, pp 2426-2433, issn 0022-5347, 8 p., 1Article

The role of antiandrogen monotherapy in the treatment of prostate cancerANDERSON, J.BJU international (Papier). 2003, Vol 91, Num 5, pp 455-461, issn 1464-4096, 7 p.Article

Effects of the anti-androgen, bicalutamide, in a reduced life-cycle study with the fathead minnow (Pimephales promelas)PANTER, G. H; GLENNON, Y. C; ROBINSON, J et al.Aquatic toxicology. 2012, Vol 114-15, pp 31-38, issn 0166-445X, 8 p.Article

Enzyme-inducing effects of bicalutamide in mouse, rat and dogMCKILLOP, D; BUTTERS, C. J; HILL, S. J et al.Xenobiotica (London. Print). 1998, Vol 28, Num 5, pp 465-478, issn 0049-8254Article

  • Page / 11